Skip to main content

Regeneron CEO hopes to have coronavirus treatment ready for human testing possibly by this summer

"How quickly that can be deployed will depend on some of the early data that we have, some animal data, what we will see in patients," Regeneron CEO Leonard Schleifer told CNBC.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.